Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context

Summary: Background: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. Exercise-stress testing is recommended in case of uncertainty; however, this approach is time-consuming and costly. Since preserved EF does not represent normal systolic function, we hy...

Full description

Bibliographic Details
Main Authors: Sören J. Backhaus, Harun Uzun, Simon F. Rösel, Alexander Schulz, Torben Lange, Richard J. Crawley, Ruben Evertz, Gerd Hasenfuß, Andreas Schuster
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422005163
_version_ 1811179580407414784
author Sören J. Backhaus
Harun Uzun
Simon F. Rösel
Alexander Schulz
Torben Lange
Richard J. Crawley
Ruben Evertz
Gerd Hasenfuß
Andreas Schuster
author_facet Sören J. Backhaus
Harun Uzun
Simon F. Rösel
Alexander Schulz
Torben Lange
Richard J. Crawley
Ruben Evertz
Gerd Hasenfuß
Andreas Schuster
author_sort Sören J. Backhaus
collection DOAJ
description Summary: Background: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. Exercise-stress testing is recommended in case of uncertainty; however, this approach is time-consuming and costly. Since preserved EF does not represent normal systolic function, we hypothesized comprehensive cardiovascular magnetic resonance (CMR) assessment of cardiac hemodynamic forces (HDF) may identify functional abnormalities in HFpEF. Methods: The HFpEF Stress Trial (DZHK-17; Clinicaltrials.gov: NCT03260621) prospectively recruited 75 patients with exertional dyspnea, preserved EF (≥50%) and signs of diastolic dysfunction (E/e’ ≥8) on echocardiography. Patients underwent rest and exercise-stress right heart catheterisation, echocardiography and CMR. The final study cohort consisted of 68 patients (HFpEF n = 34 and non-cardiac dyspnea n = 34 according to pulmonary capillary wedge pressure (PCWP)). HDF assessment included left ventricular (LV) longitudinal, systolic peak and impulse, systolic/diastolic transition, E-wave deceleration as well as A-wave acceleration forces. Follow-up after 24 months evaluated cardiovascular mortality and hospitalisation (CVH) – only two patients were lost to follow-up. Findings: HDF assessment revealed impairment of LV longitudinal function in patients with HFpEF compared to non-cardiac dyspnoea (15.8% vs. 18.3%, p = 0.035), attributable to impairment of systolic peak (38.6% vs 51.6%, p = 0.003) and impulse (20.8% vs. 24.5%, p = 0.009) forces as well as late diastolic filling (−3.8% vs −5.4%, p = 0.029). Early diastolic filling was impaired in HFpEF patients identified at rest compared with patients identified during stress only (7.7% vs. 9.9%, p = 0.004). Impaired systolic peak was associated with CVH (HR 0.95, p = 0.016), and was superior to LV global longitudinal strain assessment in prediction of CVH (AUC 0.76 vs. 0.61, p = 0.048). Interpretation: Assessment of HDF indicates impairment of LV systolic ejection force in HFpEF which is associated with cardiovascular events. Funding: German Centre for Cardiovascular Research (DZHK).
first_indexed 2024-04-11T06:36:36Z
format Article
id doaj.art-f477abf7c64f440c8921fe18fe24cf54
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-11T06:36:36Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-f477abf7c64f440c8921fe18fe24cf542022-12-22T04:39:41ZengElsevierEBioMedicine2352-39642022-12-0186104334Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in contextSören J. Backhaus0Harun Uzun1Simon F. Rösel2Alexander Schulz3Torben Lange4Richard J. Crawley5Ruben Evertz6Gerd Hasenfuß7Andreas Schuster8University Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany; School of Biomedical Engineering and Imaging Sciences, King's College London, United KingdomUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanySchool of Biomedical Engineering and Imaging Sciences, King's College London, United KingdomUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany; School of Biomedical Engineering and Imaging Sciences, King's College London, United Kingdom; Corresponding author. University Medical Centre, Georg-August-University Göttingen, Department of Cardiology and Pneumology, Robert-Koch-Str. 40, 37099, Göttingen, Germany.Summary: Background: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. Exercise-stress testing is recommended in case of uncertainty; however, this approach is time-consuming and costly. Since preserved EF does not represent normal systolic function, we hypothesized comprehensive cardiovascular magnetic resonance (CMR) assessment of cardiac hemodynamic forces (HDF) may identify functional abnormalities in HFpEF. Methods: The HFpEF Stress Trial (DZHK-17; Clinicaltrials.gov: NCT03260621) prospectively recruited 75 patients with exertional dyspnea, preserved EF (≥50%) and signs of diastolic dysfunction (E/e’ ≥8) on echocardiography. Patients underwent rest and exercise-stress right heart catheterisation, echocardiography and CMR. The final study cohort consisted of 68 patients (HFpEF n = 34 and non-cardiac dyspnea n = 34 according to pulmonary capillary wedge pressure (PCWP)). HDF assessment included left ventricular (LV) longitudinal, systolic peak and impulse, systolic/diastolic transition, E-wave deceleration as well as A-wave acceleration forces. Follow-up after 24 months evaluated cardiovascular mortality and hospitalisation (CVH) – only two patients were lost to follow-up. Findings: HDF assessment revealed impairment of LV longitudinal function in patients with HFpEF compared to non-cardiac dyspnoea (15.8% vs. 18.3%, p = 0.035), attributable to impairment of systolic peak (38.6% vs 51.6%, p = 0.003) and impulse (20.8% vs. 24.5%, p = 0.009) forces as well as late diastolic filling (−3.8% vs −5.4%, p = 0.029). Early diastolic filling was impaired in HFpEF patients identified at rest compared with patients identified during stress only (7.7% vs. 9.9%, p = 0.004). Impaired systolic peak was associated with CVH (HR 0.95, p = 0.016), and was superior to LV global longitudinal strain assessment in prediction of CVH (AUC 0.76 vs. 0.61, p = 0.048). Interpretation: Assessment of HDF indicates impairment of LV systolic ejection force in HFpEF which is associated with cardiovascular events. Funding: German Centre for Cardiovascular Research (DZHK).http://www.sciencedirect.com/science/article/pii/S2352396422005163HFpEFCardiovascular magnetic resonanceHemodynamic forceDeformation imagingStrain
spellingShingle Sören J. Backhaus
Harun Uzun
Simon F. Rösel
Alexander Schulz
Torben Lange
Richard J. Crawley
Ruben Evertz
Gerd Hasenfuß
Andreas Schuster
Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
EBioMedicine
HFpEF
Cardiovascular magnetic resonance
Hemodynamic force
Deformation imaging
Strain
title Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
title_full Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
title_fullStr Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
title_full_unstemmed Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
title_short Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
title_sort hemodynamic force assessment by cardiovascular magnetic resonance in hfpef a case control substudy from the hfpef stress trialresearch in context
topic HFpEF
Cardiovascular magnetic resonance
Hemodynamic force
Deformation imaging
Strain
url http://www.sciencedirect.com/science/article/pii/S2352396422005163
work_keys_str_mv AT sorenjbackhaus hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT harunuzun hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT simonfrosel hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT alexanderschulz hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT torbenlange hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT richardjcrawley hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT rubenevertz hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT gerdhasenfuß hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext
AT andreasschuster hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext